Overview
Common variable immunodeficiency due to TNFR (tumor necrosis factor receptor) deficiency is a condition that was previously classified as a distinct form of common variable immunodeficiency (CVID). It is now considered an obsolete classification, meaning that the medical community has reclassified or merged this condition into broader or updated disease categories. CVID in general is a group of immune system disorders where the body cannot make enough protective antibodies (immunoglobulins), leaving a person vulnerable to frequent and sometimes severe infections. In this particular subtype, the underlying problem was thought to involve defects in the TNFR signaling pathway, which plays an important role in how immune cells communicate and respond to threats. Patients with this type of immune deficiency typically experienced repeated bacterial infections, particularly of the lungs, sinuses, and ears. Some patients also developed autoimmune problems, where the immune system mistakenly attacks the body's own tissues, or had enlarged lymph nodes and spleen. Because this classification is now obsolete, patients who were previously diagnosed with this condition may have been reclassified under other forms of CVID or primary immunodeficiency. Treatment generally involves immunoglobulin replacement therapy, which provides the missing antibodies, along with antibiotics to treat and prevent infections. Patients should work closely with an immunologist to ensure they receive the most up-to-date diagnosis and management plan.
Also known as:
Key symptoms:
Frequent sinus infectionsRecurring lung infections or pneumoniaChronic ear infectionsFrequent stomach or intestinal infections with diarrheaEnlarged lymph nodesEnlarged spleenAutoimmune problems such as low blood cell countsUnexplained weight lossFatigue and low energyJoint pain or swellingSkin rashes or granulomasPoor response to vaccines
Variable
Can be inherited in different ways depending on the underlying gene
Variable
Can begin at different ages, from infancy through adulthood
FDA & Trial Timeline
3 eventsUniversity of Alabama at Birmingham — PHASE4
Avni Joshi — PHASE2
National Cancer Institute (NCI) — PHASE2
Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
Treatments
No FDA-approved treatments are currently listed for OBSOLETE: Common variable immunodeficiency due to TNFR deficiency.
3 clinical trialsare actively recruiting — trials can provide access to cutting-edge therapies.
View clinical trials →Specialists
View all specialists →No specialists are currently listed for OBSOLETE: Common variable immunodeficiency due to TNFR deficiency.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to OBSOLETE: Common variable immunodeficiency due to TNFR deficiency.
Community
No community posts yet. Be the first to share your experience with OBSOLETE: Common variable immunodeficiency due to TNFR deficiency.
Start the conversation →Latest news about OBSOLETE: Common variable immunodeficiency due to TNFR deficiency
No recent news articles for OBSOLETE: Common variable immunodeficiency due to TNFR deficiency.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Questions for your doctor
Bring these to your next appointment
- Q1.Since this classification is now obsolete, what is my most accurate current diagnosis?,Should I have updated genetic testing to better understand my condition?,What type of immunoglobulin replacement therapy is best for me — IV or subcutaneous?,How often should I have my immunoglobulin levels and lung function checked?,What vaccines are safe for me, and which ones should I avoid?,What signs of infection or complications should prompt me to seek emergency care?,Are my family members at risk, and should they be tested?
Common questions about OBSOLETE: Common variable immunodeficiency due to TNFR deficiency
What is OBSOLETE: Common variable immunodeficiency due to TNFR deficiency?
Common variable immunodeficiency due to TNFR (tumor necrosis factor receptor) deficiency is a condition that was previously classified as a distinct form of common variable immunodeficiency (CVID). It is now considered an obsolete classification, meaning that the medical community has reclassified or merged this condition into broader or updated disease categories. CVID in general is a group of immune system disorders where the body cannot make enough protective antibodies (immunoglobulins), leaving a person vulnerable to frequent and sometimes severe infections. In this particular subtype, th
Are there clinical trials for OBSOLETE: Common variable immunodeficiency due to TNFR deficiency?
Yes — 3 recruiting clinical trials are currently listed for OBSOLETE: Common variable immunodeficiency due to TNFR deficiency on UniteRare. See the clinical trials section on this page for phase, sponsor, and site details sourced from ClinicalTrials.gov.